K170844 is an FDA 510(k) clearance for the Gemini-C Hybrid Cervical Interbody System. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).
Submitted by Osseus Fusion Systems, LLC (Dallas, US). The FDA issued a Cleared decision on July 3, 2017, 104 days after receiving the submission on March 21, 2017.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..